Sarah Fletcher Mercaldo, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mammography | 15 | 2024 | 2434 | 0.910 |
Why?
|
Breast Neoplasms | 26 | 2024 | 21187 | 0.710 |
Why?
|
Technology, Radiologic | 1 | 2019 | 160 | 0.650 |
Why?
|
Thoracic Diseases | 1 | 2019 | 99 | 0.620 |
Why?
|
Back Pain | 1 | 2021 | 547 | 0.570 |
Why?
|
Decision Support Systems, Clinical | 1 | 2021 | 1177 | 0.390 |
Why?
|
Early Detection of Cancer | 13 | 2024 | 3238 | 0.370 |
Why?
|
Magnetic Resonance Imaging | 11 | 2024 | 36861 | 0.370 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 3 | 2022 | 933 | 0.340 |
Why?
|
Carcinoma, Ductal, Breast | 3 | 2022 | 1093 | 0.340 |
Why?
|
Lumbar Vertebrae | 3 | 2024 | 1889 | 0.310 |
Why?
|
Biostatistics | 1 | 2020 | 165 | 0.300 |
Why?
|
Delayed Diagnosis | 2 | 2021 | 468 | 0.280 |
Why?
|
Breast | 8 | 2022 | 1976 | 0.250 |
Why?
|
Emergency Service, Hospital | 3 | 2023 | 7956 | 0.240 |
Why?
|
Astronauts | 2 | 2022 | 94 | 0.230 |
Why?
|
Retrospective Studies | 30 | 2024 | 81892 | 0.200 |
Why?
|
Polyps | 1 | 2024 | 200 | 0.200 |
Why?
|
Hospitalization | 1 | 2021 | 10845 | 0.190 |
Why?
|
Weightlessness | 1 | 2022 | 103 | 0.190 |
Why?
|
Sensitivity and Specificity | 8 | 2024 | 14751 | 0.170 |
Why?
|
Brain Edema | 1 | 2024 | 607 | 0.170 |
Why?
|
Appointments and Schedules | 1 | 2024 | 443 | 0.170 |
Why?
|
Data Interpretation, Statistical | 1 | 2020 | 2714 | 0.170 |
Why?
|
Healthcare Disparities | 3 | 2021 | 3421 | 0.170 |
Why?
|
Communication Barriers | 1 | 2023 | 419 | 0.160 |
Why?
|
Space Flight | 1 | 2022 | 219 | 0.160 |
Why?
|
Pneumothorax | 1 | 2022 | 393 | 0.160 |
Why?
|
Aged | 28 | 2024 | 171790 | 0.160 |
Why?
|
Middle Aged | 32 | 2024 | 223740 | 0.160 |
Why?
|
Ultrasonography, Mammary | 1 | 2021 | 241 | 0.160 |
Why?
|
Choristoma | 1 | 2020 | 205 | 0.160 |
Why?
|
Incidental Findings | 1 | 2024 | 697 | 0.160 |
Why?
|
Adenocarcinoma, Papillary | 1 | 2019 | 86 | 0.160 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2020 | 1756 | 0.150 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2019 | 211 | 0.150 |
Why?
|
Utilization Review | 1 | 2019 | 384 | 0.140 |
Why?
|
Mass Screening | 7 | 2023 | 5455 | 0.140 |
Why?
|
Models, Statistical | 2 | 2020 | 5107 | 0.140 |
Why?
|
Low Back Pain | 2 | 2024 | 990 | 0.130 |
Why?
|
Elasticity Imaging Techniques | 1 | 2021 | 398 | 0.130 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2018 | 175 | 0.130 |
Why?
|
Female | 38 | 2024 | 397464 | 0.120 |
Why?
|
Lung Neoplasms | 4 | 2023 | 13593 | 0.120 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2021 | 522 | 0.120 |
Why?
|
Lung Diseases, Interstitial | 1 | 2023 | 944 | 0.120 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2018 | 282 | 0.120 |
Why?
|
Biomedical Research | 1 | 2020 | 3463 | 0.120 |
Why?
|
Humans | 48 | 2024 | 768887 | 0.110 |
Why?
|
Prostate | 1 | 2022 | 1781 | 0.110 |
Why?
|
Adult | 21 | 2024 | 223818 | 0.110 |
Why?
|
Workload | 1 | 2019 | 852 | 0.110 |
Why?
|
Pneumonectomy | 1 | 2020 | 1159 | 0.110 |
Why?
|
Artificial Intelligence | 2 | 2024 | 2665 | 0.100 |
Why?
|
Venous Thrombosis | 1 | 2022 | 1321 | 0.100 |
Why?
|
Mastectomy, Segmental | 3 | 2022 | 960 | 0.100 |
Why?
|
Pancreatic Neoplasms | 2 | 2020 | 5443 | 0.100 |
Why?
|
Calcinosis | 1 | 2020 | 1481 | 0.100 |
Why?
|
Observer Variation | 3 | 2024 | 2623 | 0.100 |
Why?
|
Pneumonia | 1 | 2023 | 2163 | 0.100 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2021 | 3411 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 3 | 2024 | 20776 | 0.090 |
Why?
|
Ultrasonography | 1 | 2024 | 6001 | 0.090 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15471 | 0.090 |
Why?
|
Prospective Studies | 7 | 2024 | 54950 | 0.080 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3858 | 0.080 |
Why?
|
Image Enhancement | 1 | 2019 | 2898 | 0.080 |
Why?
|
Ambulatory Care | 1 | 2019 | 2783 | 0.070 |
Why?
|
Thrombosis | 1 | 2022 | 2956 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2024 | 7460 | 0.070 |
Why?
|
Male | 16 | 2024 | 365249 | 0.070 |
Why?
|
Insurance, Health | 1 | 2019 | 2518 | 0.070 |
Why?
|
Lung | 2 | 2023 | 10097 | 0.060 |
Why?
|
Biopsy, Needle | 2 | 2022 | 1627 | 0.060 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3538 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5434 | 0.060 |
Why?
|
Medicare | 1 | 2023 | 6888 | 0.060 |
Why?
|
Gallbladder Diseases | 1 | 2024 | 139 | 0.050 |
Why?
|
United States National Aeronautics and Space Administration | 1 | 2022 | 16 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3837 | 0.050 |
Why?
|
Substance-Related Disorders | 1 | 2019 | 4429 | 0.050 |
Why?
|
Reproducibility of Results | 4 | 2021 | 20244 | 0.050 |
Why?
|
Architectural Accessibility | 1 | 2021 | 24 | 0.050 |
Why?
|
Time Factors | 2 | 2024 | 40266 | 0.050 |
Why?
|
Mental Disorders | 1 | 2022 | 6879 | 0.050 |
Why?
|
Neoplasm Invasiveness | 2 | 2020 | 3629 | 0.050 |
Why?
|
Axilla | 1 | 2024 | 625 | 0.050 |
Why?
|
Aged, 80 and over | 6 | 2022 | 59738 | 0.050 |
Why?
|
Diagnosis, Differential | 3 | 2021 | 13020 | 0.050 |
Why?
|
Jugular Veins | 1 | 2022 | 211 | 0.050 |
Why?
|
United States | 7 | 2024 | 73180 | 0.050 |
Why?
|
Mucin 5AC | 1 | 2020 | 96 | 0.040 |
Why?
|
Societies, Medical | 2 | 2024 | 3967 | 0.040 |
Why?
|
Community Health Centers | 1 | 2024 | 469 | 0.040 |
Why?
|
Computers | 1 | 2022 | 592 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2022 | 11229 | 0.040 |
Why?
|
Lumbosacral Region | 1 | 2021 | 294 | 0.040 |
Why?
|
Time | 1 | 2021 | 552 | 0.040 |
Why?
|
Odds Ratio | 2 | 2022 | 9682 | 0.040 |
Why?
|
Pancreatic Ducts | 1 | 2020 | 330 | 0.040 |
Why?
|
Logistic Models | 2 | 2022 | 13317 | 0.040 |
Why?
|
Obesity | 1 | 2019 | 13087 | 0.030 |
Why?
|
Feedback | 1 | 2020 | 799 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15662 | 0.030 |
Why?
|
Risk Factors | 5 | 2022 | 74971 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2022 | 1321 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2018 | 963 | 0.030 |
Why?
|
Risk Assessment | 3 | 2022 | 24330 | 0.030 |
Why?
|
Consensus | 1 | 2024 | 3214 | 0.030 |
Why?
|
Patient Compliance | 1 | 2024 | 2701 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9442 | 0.030 |
Why?
|
Language | 1 | 2023 | 1559 | 0.030 |
Why?
|
Carcinoma in Situ | 1 | 2019 | 788 | 0.030 |
Why?
|
Mastectomy | 1 | 2021 | 1850 | 0.030 |
Why?
|
Needs Assessment | 1 | 2019 | 1142 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2022 | 2487 | 0.030 |
Why?
|
Probability | 1 | 2018 | 2483 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3621 | 0.020 |
Why?
|
Tumor Burden | 1 | 2018 | 1913 | 0.020 |
Why?
|
Benchmarking | 1 | 2018 | 1058 | 0.020 |
Why?
|
Radiography | 1 | 2022 | 6991 | 0.020 |
Why?
|
Pandemics | 2 | 2021 | 8745 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 1232 | 0.020 |
Why?
|
Body Composition | 1 | 2020 | 2461 | 0.020 |
Why?
|
Program Evaluation | 1 | 2019 | 2507 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2024 | 7860 | 0.020 |
Why?
|
Reoperation | 1 | 2020 | 4342 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2018 | 2056 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6805 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5890 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 26384 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2784 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2018 | 2734 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2019 | 1946 | 0.020 |
Why?
|
Cohort Studies | 2 | 2020 | 41800 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3903 | 0.020 |
Why?
|
Contrast Media | 1 | 2019 | 5334 | 0.020 |
Why?
|
Length of Stay | 1 | 2020 | 6525 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 14795 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12093 | 0.020 |
Why?
|
Incidence | 1 | 2024 | 21545 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10115 | 0.020 |
Why?
|
Computer Simulation | 1 | 2019 | 6289 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4077 | 0.010 |
Why?
|
Young Adult | 2 | 2021 | 60110 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18454 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15875 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5520 | 0.010 |
Why?
|
Child, Preschool | 1 | 2022 | 42684 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39394 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2020 | 15889 | 0.010 |
Why?
|
Adolescent | 1 | 2022 | 89247 | 0.010 |
Why?
|
Mice | 1 | 2020 | 82074 | 0.010 |
Why?
|
Animals | 1 | 2020 | 169408 | 0.000 |
Why?
|